NVIV - InVivo Therapeutics Holdings Corp Stock Price, Fair Value and News

$0.370.00 (0.00%)

Market Closed

NVIV Stock Valuation Analysis

Valuation

Max Portfolio %

NVIV Price Action

NVIV RSI Chart

NVIV Stock Valuation Analysis

Valuation

Max Portfolio %

NVIV Valuation

NVIV Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NVIV Fundamentals

NVIV Earnings

NVIV Profitability

NVIV Investor Care

Revenue & Growth

About InVivo Therapeutics Holdings Corp

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

CEO	Dr. Richard M. Toselli
WEBSITE	invivotherapeutics.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	6